Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G - Leap Therapeutics, Inc. | StockGist | StockGist

Companies
LPTX
SCHEDULE 13G

Home Top Movers Companies Concepts

Home Filings LPTXSCHEDULE 13G

SCHEDULE 13G

Beneficial Ownership

Leap Therapeutics, Inc.

Filed Nov 18, 2025

Accepted Nov 17, 2025, 7:00 PM ET

CIK 0001509745

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Reporting Person

LEAP THERAPEUTICS, INC.

Person Type

IN

CUSIP: 52187K200

Amendment History

3 filings

SCHEDULE 13G
Original
Viewing
Nov 18, 20250001172661-25-005208
SCHEDULE 13G/A
Amendment 1
Feb 12, 20260001123292-26-000163
SCHEDULE 13G/A
Amendment 2
Latest
Feb 12, 20260001123292-26-000163

Recent Filings

Leap Therapeutics, Inc.3 weeks ago

Leap Therapeutics, Inc.1 months ago

Leap Therapeutics, Inc.3 months ago

Leap Therapeutics, Inc.3 months ago

Leap Therapeutics, Inc.3 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice